Shawn O'Brien, CEO of Genomind

About Shawn O'Brien:

Shawn currently serves as the Chairman and CEO of Genomind Inc., a private personalized mental health business based in King of Prussia, which improves the lives of many around the globe through insights provided from its world-class genetic lab and medical team.

A biotech and big pharma executive leader with over 35 years’ experience in building highly successful global enterprises. Shawn has extensive international experience in business development, marketing, selling, licensing, researching & developing both small and large molecules, with over 7 multi-Billion dollar product launches.

Since leaving big pharma over 15 years ago, Shawn has been a serial entrepreneur leading 4 biotech companies before his current role at Genomind. In addition he has broad healthcare provider experience in USA, UK and Canada.

Shawn is the Chairman of Alto Pharma, Co-Chair of the Hubert Schoemaker Classic, Advisory Board member of both; The Greater Philadelphia Life Sciences Congress and Life Sciences Cares Philadelphia.

placeholder image

Sponsored Content

Sponsored Content